Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Testosterone

    Virtual Booth

    Contact Supplier

    Testosterone

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Testosterone

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    Virilon IM

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 560Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clinicians' Choice Accredits TestoPrime for Men 50+ in 2026
    Clinicians' Choice Accredits TestoPrime for Men 50+ in 2026

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248796/0/en/Testosterone-Booster-Supplement-for-Men-Over-50-TestoPrime-Medically-Accredited-by-Clinicians-Choice-in-2026.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    VTT Develops Rapid Method For Hormone & Toxin Detection
    VTT Develops Rapid Method For Hormone & Toxin Detection

    24 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-24/rapid-and-accurate-method-from-vtt-for-detecting-hormones-toxins-and-other-small-molecules

    PHARMIWEB
    24 Feb 2026
    Share Share
    BoomRx Expands Testosterone Replacement Therapy Beyond Clinic
    BoomRx Expands Testosterone Replacement Therapy Beyond Clinic

    11 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/boomrx-expands-testosterone-replacement-therapy-trt-beyond-the-clinic-302684745.html

    PR NEWSWIRE
    11 Feb 2026
    Share Share
    Apotex Licenses Rights to Testosterone Replacement therapy
    Apotex Licenses Rights to Testosterone Replacement therapy

    06 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grunenthal-licenses-exclusive-canadian-rights-to-testosterone-replacement-therapy-nebido-to-apotex-302680392.html

    PR NEWSWIRE
    06 Feb 2026
    Share Share
    Aviva Bio Guides FDA On Women's Testosterone Therapy Path
    Aviva Bio Guides FDA On Women's Testosterone Therapy Path

    26 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260126103179/en/Aviva-Bio-Announces-FDA-Guidance-on-Development-Pathway-for-Womens-Testosterone-Therapy-and-New-Evidence-of-a-Reduced-Risk-of-Breast-Cancer-Cell-Proliferation-for-AVA-291

    BUSINESSWIRE
    26 Jan 2026
    Share Share
    Enforcement Report - Week of January 21, 2026
    Enforcement Report - Week of January 21, 2026

    21 Jan 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-21-2026-24128.pdf

    FDA
    21 Jan 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.